190 related articles for article (PubMed ID: 2547527)
1. Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.
Coley HM; Twentyman PR; Workman P
Cancer Chemother Pharmacol; 1989; 24(5):284-90. PubMed ID: 2547527
[TBL] [Abstract][Full Text] [Related]
2. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.
Coley HM; Twentyman PR; Workman P
Biochem Pharmacol; 1989 Dec; 38(24):4467-75. PubMed ID: 2604747
[TBL] [Abstract][Full Text] [Related]
3. Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
Coley HM; Twentyman PR; Workman P
Anticancer Drug Des; 1992 Dec; 7(6):471-81. PubMed ID: 1337431
[TBL] [Abstract][Full Text] [Related]
4. The efflux of anthracyclines in multidrug-resistant cell lines.
Coley HM; Twentyman PR; Workman P
Biochem Pharmacol; 1993 Oct; 46(8):1317-26. PubMed ID: 7902089
[TBL] [Abstract][Full Text] [Related]
5. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.
Robson C; Wright KA; Twentyman PR; Lambert PA; Griffin RJ
Biochem Pharmacol; 1998 Oct; 56(7):807-16. PubMed ID: 9774142
[TBL] [Abstract][Full Text] [Related]
6. 9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance.
Coley HM; Twentyman PR; Workman P
Eur J Cancer; 1990; 26(6):665-7. PubMed ID: 1975502
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance in human lung cancer cell lines: cross-resistance studies and effects of the calcium transport blocker, verapamil.
Twentyman PR; Fox NE; Bleehen NM
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1355-8. PubMed ID: 3019960
[TBL] [Abstract][Full Text] [Related]
8. Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
Shrivastava P; Hanibuchi M; Yano S; Parajuli P; Tsuruo T; Sone S
Cancer Chemother Pharmacol; 1998; 42(6):483-90. PubMed ID: 9788575
[TBL] [Abstract][Full Text] [Related]
9. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
Coley HM; Amos WB; Twentyman PR; Workman P
Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
11. Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporins.
Twentyman PR
Br J Cancer; 1988 Mar; 57(3):254-8. PubMed ID: 2833299
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
Ishida Y; Shimada Y; Shimoyama M
Jpn J Cancer Res; 1990 Aug; 81(8):834-41. PubMed ID: 2118896
[TBL] [Abstract][Full Text] [Related]
13. Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.
Twentyman PR; Fox NE; Wright KA; Bleehen NM
Br J Cancer; 1986 Apr; 53(4):529-37. PubMed ID: 3011054
[TBL] [Abstract][Full Text] [Related]
14. The expression of mdr-1-related gp-170 and its correlation with anthracycline resistance in renal cell carcinoma cell lines and multidrug-resistant sublines.
Yu DS; Chang SY; Ma CP
Br J Urol; 1998 Oct; 82(4):544-7. PubMed ID: 9806185
[TBL] [Abstract][Full Text] [Related]
15. In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay.
Horiuchi N; Nakagawa K; Sasaki Y; Minato K; Fujiwara Y; Nezu K; Ohe Y; Saijo N
Cancer Chemother Pharmacol; 1988; 22(3):246-50. PubMed ID: 2842080
[TBL] [Abstract][Full Text] [Related]
16. 9-alkyl anthracyclines. Absence of cross-resistance to adriamycin in human and murine cell cultures.
Scott CA; Westmacott D; Broadhurst MJ; Thomas GJ; Hall MJ
Br J Cancer; 1986 May; 53(5):595-600. PubMed ID: 3718817
[TBL] [Abstract][Full Text] [Related]
17. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
Watanabe T; Naito M; Kokubu N; Tsuruo T
J Natl Cancer Inst; 1997 Apr; 89(7):512-8. PubMed ID: 9086008
[TBL] [Abstract][Full Text] [Related]
18. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.
Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ
J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay.
Twentyman PR; Fox NE; Rees JK
Br J Haematol; 1989 Jan; 71(1):19-24. PubMed ID: 2917126
[TBL] [Abstract][Full Text] [Related]
20. Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.
Coley HM; Workman P; Twentyman PR
Br J Cancer; 1991 Mar; 63(3):351-7. PubMed ID: 1672252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
